| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10000548 | GAILTTMLATR | T | 6 | 307 |
| 10000549 | GAILTTMLATR | T | 6 | 307 |
| 10020027 | STVASMMHR | S | 5 | 280 |
| 10020706 | S | 280 | ||
| 10020707 | T | 287 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10000548 | MS | HTP | unambiguous | human | brain | Alzheimers disease/control | 0.02962216 | 0.56141338 | 28657654 | |
| 10000549 | MS | HTP | unambiguous | human | brain | Alzheimers disease/control | 0.423021945 | 0.168155699 | 28657654 | |
| 10020027 | MS, site-specific mutagenesis | LTP | unambiguous | human | HEK293 cells | 24077098 | This site was described as S279 in the original paper | |||
| 10020706 | Site-specific mutagenesis | LTP | unambiguous | human | HEK 293 cells | 33926209 | ||||
| 10020707 | Site-specific mutagenesis | LTP | unambiguous | human | HEK 293 cells | 33926209 |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10000548 | GAILTTMLATR | T | 6 | 307 | MS | HTP | unambiguous | human | brain | 28657654 | |
| 10000549 | GAILTTMLATR | T | 6 | 307 | MS | HTP | unambiguous | human | brain | 28657654 | |
| 10020027 | STVASMMHR | S | 5 | 280 | MS, site-specific mutagenesis | LTP | unambiguous | human | HEK293 cells | 24077098 | This site was described as S279 in the original paper |
| 10020706 | S | 280 | Site-specific mutagenesis | LTP | unambiguous | human | HEK 293 cells | 33926209 | |||
| 10020707 | T | 287 | Site-specific mutagenesis | LTP | unambiguous | human | HEK 293 cells | 33926209 |